<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00461435</url>
  </required_header>
  <id_info>
    <org_study_id>SS01</org_study_id>
    <nct_id>NCT00461435</nct_id>
  </id_info>
  <brief_title>Slowing the Degenerative Process, Long Lasting Effect of Hyperbaric Oxygen Therapy in Retinitis Pigmentosa</brief_title>
  <official_title>Slowing the Degenerative Process, Long Lasting Effect of Hyperbaric Oxygen Therapy in Retinitis Pigmentosa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Policlinico Umberto I</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Policlinico Umberto I</source>
  <brief_summary>
    <textblock>
      Our aim was to assess the role and usefulness of Hyperbaric oxygen therapy in a long lasting
      period, assessing its efficacy on rescuing retinal photoreceptors and preserving visual
      function in retinitis pigmentosa.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single</masking>
  </study_design_info>
  <condition>Retinitis Pigmentosa</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>hyperbaric oxygen therapy</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with clearly hereditary RP (we performed to all of them genetic analysis for
             rhodopsin, and peripherin genes, only 4 patient with ADRP showed point mutation 3 on
             codon 135 and 1 on codon 347); best corrected visual acuity (BCVA) ≥ 0.50 logMAR;
             visual field ≥ 3 degree diameter circle; recordable ERG.

        Exclusion Criteria:

          -  Exclusion criteria were: patients with sporadic RP; BCVA ≤ 0.50 logMAR; visual field ≤
             3 degree diameter circle; not recordable ERG.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Enzo Maria Vingolo, PH.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Policlinico Umberto I, Dipartimento di Oftalmologia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Azienda Policlinico Umberto I</name>
      <address>
        <city>Rome</city>
        <zip>00161</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 17, 2007</study_first_submitted>
  <study_first_submitted_qc>April 17, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2007</study_first_posted>
  <last_update_submitted>April 17, 2007</last_update_submitted>
  <last_update_submitted_qc>April 17, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 18, 2007</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinitis</mesh_term>
    <mesh_term>Retinitis Pigmentosa</mesh_term>
    <mesh_term>Cone-Rod Dystrophies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

